Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Tiaa-cref Individual & Institutional Services »

Fate Therapeutics shares owned by Tiaa-cref Individual & Institutional Services

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Tiaa-cref Individual & Institutional Services from 13F filings

Historical chart of Tiaa-cref Individual & Institutional Services investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Tiaa-cref Individual & Institutional Services consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Quarterly reported holdings in Fate Therapeutics by Tiaa-cref Individual & Institutional Services

Quarter filed	Position value	Share count	Share price at filing
2026-03-31	$21k	18k	1.20

More positions owned by Tiaa-cref Individual & Institutional Services

Ishares Core Msci Eafe Etf Exchange Traded Fund (IEFA)

Vanguard Growth Etf Exchange Traded Fund (VUG)

Vanguard Value Etf Exchange Traded Fund (VTV)

Vanguard Ftse Developed Etf Exchange Traded Fund (VEA)

Ishares Russell Top 200 Grow Exchange Traded Fund (IWY)

Ishares Russell Top 200 Valu Exchange Traded Fund (IWX)

Ishares Core Msci Emerging Exchange Traded Fund (IEMG)

Ishares Mbs Etf Exchange Traded Fund (MBB)

Vanguard Tax-exempt Bond Etf Exchange Traded Fund (VTEB)

Ishares Core U.s. Aggregate Exchange Traded Fund (AGG)

Vanguard Russell 1000 Growth Exchange Traded Fund (VONG)

Ishares National Muni Bond E Exchange Traded Fund (MUB)

Ste Str Spdr Pt Dw Eu Etf Exchange Traded Fund (SPDW)

Vanguard Russell 1000 Value Exchange Traded Fund (VONV)

Ishares Broad Usd Investment Exchange Traded Fund (USIG)

View all positions for Tiaa-cref Individual & Institutional Services

Top funds holding Fate Therapeutics

Redmile Group

BlackRock

Vanguard Group

Vanguard Capital Management

Vanguard Portfolio Management

Acadian Asset Management

Two Sigma Investments

Johnson & Johnson

AQR Capital Management

Geode Capital Management

Renaissance Technologies

State Street Corporation

UBS Group

Goldman Sachs Group

Tang Capital Management

View all funds holding Fate Therapeutics

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z